
You're transforming medicine.
We're preserving product integrity.
The only ultra-low temperature, low-pressure nitrogen dioxide (NO₂) sterilization platform designed to protect your prefilled syringes and biologic drug-device combination products from ingress and protein degradation.

You’re advancing medical innovation.
We’re optimizing supply chain efficiency.
Shorter sterilization cycles, combined with no need to off-gas, accelerates batch release and supply chain timelines.

You’re creating life-changing products.
We’re offering an EtO alternative.
NO2 sterilization delivers sterility assurance leaving none of the carcinogenic, cytotoxic or teratogenic residuals associated with ethylene oxide (EtO).
You’re transforming medicine. We’re preserving product integrity.
You’re advancing medical innovation. We’re optimizing supply chain efficiency.
You’re creating life-changing products. We’re offering an EtO alternative.
Trusted by
industry leaders
Companies partnering with Noxilizer include Fortune 150 biotech companies, pharmaceutical companies, and medical device manufacturers
Sterilization platform of choice
Proven regulatory success
13
Years offering proven lab services creating bespoke sterilization protocols
Our Certifications
Which best describes you?
The right sterilant for today's medical innovations
Noxilizer, with its proprietary NO2 sterilization technology, opens new avenues for innovation by offering an efficient and scalable alternative to traditional sterilization methods, with several key advantages that make it particularly effective in the sterilization of ophthalmic prefilled syringes, biologic drug-device combination products, and other medical innovations that are compromised by traditional sterilization technologies.

Effective
- Delivers proven sterility without material damage
- Compatible with complex materials and packaging

Works where other approaches don't
- Preserves sensitive drugs and devices
- Maintains drug stability in combination products
- Minimizes risk of plunger movement

Regulatory Readiness
- Confidence – Lower regulatory and submission risk
- Support – Expert support for filing

Support from R&D
to commercialization
Consulting and expert advice
R&D studies: early proof of concept through to validation
Expose and return, feasibility, scaling, process definition, and validation
Regulatory support
IP licensing
Coming soon in 2027
Contract sterilization
Fast turnaround. Release product in days, not weeks
- Strategically located near major pharmaceutical and CDMO hubs – next to Baltimore Washington International Airport (I-95/I-295)
- Door-to-door processing in as little as 2 days
- Short sterilization cycles (6–12 hours)
- Integrated release testing & batch documentation
- On-site final packaging capability
Lower product risk. A resilient sterilization partner built for supply assurance
- 5 Sterilization systems enabling commercial-scale capacity exceeding 12.5 million prefilled syringes annually
- Cold-chain enabled with on-site cold storage
- Redundant biological indicators manufacturing & backup power systems
- Full safety, maintenance, environmental, and qualification management
Built to sterilize customers’ pharmaceutical and combination products within their own validated production process
- ISO 13485:2016 certified
- CE Mark Compliant*
- ISO 14937:2009 aligned
*CE marked as industrial equipment (Machinery Directive 2006/42/EC, EMC, Low Voltage, and Pressure Equipment Directives as applicable)
- 13+ years of low-temperature sterilization expertise
- In-house microbiology laboratory
- Materials science support team
- Development, validation, and routine processing support
NO2 sterilization is the only method that allows my company to use a plastic syringe, which is the best choice for our drug and for our patients.
Fortune 150 Biotech Customer










